After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE BioDelivery Sciences International, Inc.
Small-caps could also benefit from abating tax-loss selling.
These small-caps are woefully undervalued after getting shellacked in October.
BioDelivery Sciences, Progenics Pharma and Sequential Brands are off-the-radar small-caps poised for a big year in 2017.
BioDelivery Sciences' (BDSI) stock rating was boosted at Janney Capital on Friday.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.